| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 12/03/2008 | EP1480954B1 Vanilloid receptor modulators |
| 12/03/2008 | EP1478366B1 Pharmaceutical combinations of meloxicam, codeine phosphate and paracetamol |
| 12/03/2008 | EP1423388B1 2-arylamino-pyrimidines for the treatment of gsk3-related disorders |
| 12/03/2008 | EP1419129B1 Use of branched-chain fatty acids and derivatives thereof for the treatment of pain |
| 12/03/2008 | EP1383787B1 Sapogenin derivatives, their synthesis and use |
| 12/03/2008 | EP1377540B1 Inhibitors of integrin alpha-v-beta-6 |
| 12/03/2008 | EP1373218B9 Imidazolyl derivatives useful as histamine h3 receptor ligands |
| 12/03/2008 | EP1213975B1 Method for extracting compounds of furan lipids and polyhydroxylated fatty alcohols of avocado |
| 12/03/2008 | EP1121140B1 Method for screening for anti-amyloidogenic properties and method for treatment of neurodegenerative disease |
| 12/03/2008 | EP1079804B1 Pharmaceutical compositions comprising an amphoteric surfactant an polypropoxylated cetyl alcohol and a polar drug |
| 12/03/2008 | EP1068202B1 1-(3-heteroarylpropyl- or -prop-2-enyl)-4-benzylpiperidines used as nmda receptor antagonists |
| 12/03/2008 | EP0900200B1 Pharmaceutical compositions for prevention and treatment of central nervous system disorders |
| 12/03/2008 | EP0812208B1 Pharmaceutical compositions for controlled release of soluble receptors |
| 12/03/2008 | CN101316853A Oxazolopyridine derivatives as SIRTUIN modulators |
| 12/03/2008 | CN101316851A Thienopyrimidinone derivatives as melanin concentrating hormone receptor-1 antagonists |
| 12/03/2008 | CN101316849A 1H-indazoles, benzothiazoles, 1,2-benzoisoxazoles, 1,2-benzoisothiazoles, and chromones and preparation and uses thereof |
| 12/03/2008 | CN101316844A Inhibitors of diacylglycerol acyltransferase (DGAT) |
| 12/03/2008 | CN101316833A Aminoacid derivatives containing a disulfanyl group in the form of mixed disulfanyl and aminopeptidase n inhibitors |
| 12/03/2008 | CN101316521A Polar lipid mixtures, their preparation and uses |
| 12/03/2008 | CN101316517A Oral composition and method for stress reduction associated with smoking cessation |
| 12/03/2008 | CN101314604A 7 alpha-substituted phenyl-6 alpha, alpha-endo-ethylidene(ethenylidene)-tetrahydrochysene paramorphine derivant or its salt, preparation method and application thereof |
| 12/03/2008 | CN101314591A Novel pyrazoles highly-selective marijuana acceptor-1antagon and/or reversed activation agent |
| 12/03/2008 | CN101314590A Chemical synthesis method for oxcarbazepine |
| 12/03/2008 | CN101314027A Sea backthern lysine particle |
| 12/03/2008 | CN101314021A Chinese medicinal composition for dispelling wind and relieving paralysis |
| 12/03/2008 | CN101314018A Matrimony vine chewing gum for attention centralization |
| 12/03/2008 | CN101314017A Traditional Chinese medicine preparation for treating paraplegia |
| 12/03/2008 | CN101314014A Capsule for paraplegia |
| 12/03/2008 | CN101314001A Chinese medicinal composition for treating vascular dementia and preparation method thereof |
| 12/03/2008 | CN101314000A Gastrodia tuber eucommia health care capsule and preparation method thereof |
| 12/03/2008 | CN101313990A Application of a Chinese medicinal composition in preparing medicament for treating neurosis |
| 12/03/2008 | CN101313987A Application of lily aqueous extract in anti-anxiety effect |
| 12/03/2008 | CN101313975A Anti-neurasthenic medicine liqueur |
| 12/03/2008 | CN101313967A Novel uses of traditional Chinese medicine combination for improving capacity for liquor |
| 12/03/2008 | CN101313954A Traditional Chinese medicine externally used effervescing agent (tablet) for pedicuring |
| 12/03/2008 | CN101313936A Medicament composition for dispelling wind and relieving pain, preparation method and quality control method thereof |
| 12/03/2008 | CN101313924A Preparation of low sugar panax ginseng and uses thereof |
| 12/03/2008 | CN101313922A Method for obtaining extract from several frequently seen plants and uses of the extract |
| 12/03/2008 | CN101313920A Application of truffle extract in preparing foods, medicine for treating endocrine dyscrasia diseases |
| 12/03/2008 | CN101313912A Application of echinacoside in preparing medicament for treating parkinsonism |
| 12/03/2008 | CN101313908A Composition for treating autonomic nerve disorder, preparation and uses thereof |
| 12/03/2008 | CN101313903A Medicament composition containing escitalopram |
| 12/03/2008 | CN101313814A Health-care bedding and its making method |
| 12/03/2008 | CN101313752A Method for preparing naturally cooked panax ginseng |
| 12/03/2008 | CN100439399C Human antibodies that bind human IL-12 and methods for producing |
| 12/03/2008 | CN100439397C Crystallization of IGF-1 |
| 12/03/2008 | CN100439396C Polypeptide of ramification of ciliary nerves nutrilite for curing obesity |
| 12/03/2008 | CN100439394C Pharmaceutical use for secreted bacterial effector proteins |
| 12/03/2008 | CN100439373C Oxycodone-hydrochloride polymorhs |
| 12/03/2008 | CN100439370C Trifluoromethylpurines as phosphodiesterase 4 inhibitors |
| 12/03/2008 | CN100439332C Novel thiourea derivatives and the pharmaceutical compositions containing thd same |
| 12/03/2008 | CN100439330C Aromatic oxyphenyl and aromatic sulfanylphenyl derivatives |
| 12/03/2008 | CN100438912C Self-assembled luminous current-conducting nano medicine crystal and ultra-thin film and preparation method thereof |
| 12/03/2008 | CN100438906C The use of copolymer 1 and related peptides and polypeptides and T cell treated therewith for neuroprotective therapy |
| 12/03/2008 | CN100438905C Stable liquid formulations of botulinum toxin |
| 12/03/2008 | CN100438889C Compound Chinese patent drug |
| 12/03/2008 | CN100438877C (20s) 1alpha-hydroxy-2alpha-methyl and 2beta-methyl-19-nor-vitamin D3 and their uses |
| 12/03/2008 | CN100438876C Use of 20(S)-protopanoxadiol in preparation of antidepressant medicine |
| 12/03/2008 | CN100438875C Methods for increasing the therapeutic response to electroconvulsive therapy |
| 12/03/2008 | CN100438870C Method for treating diseases with omega interferon |
| 12/03/2008 | CN100438863C Freeze dried powder injection of tramadol hydrochloride and its preparation process |
| 12/03/2008 | CN100438860C (f)-cycloolivil as antioxidant obtained from stereospermum personatum |
| 12/03/2008 | CN100438859C Transdermal therapeutic system (TTS) with fentanyl as active ingredient |
| 12/02/2008 | US7459601 Animal model for use in monitoring aggregation of alpha -synuclein non-amyloid component (NAC) and identifying agent for treatment of nervous system disorders; neuroprotective agents |
| 12/02/2008 | US7459540 Fibroblast growth factor-like polypeptides |
| 12/02/2008 | US7459476 beta-secretase enzyme inhibitors; inhibiting deposition of A beta peptide; P-glycoprotein inhibitor; Down's syndrome, mild cognitive impairment; cerebral amyloid angiopathy, degenerative dementias; imidazole deivatives |
| 12/02/2008 | US7459470 For example, N-(Isoquinolin-3-yl)-2-(4-pyridylmethyl)aminobenzoic acid amide-N-oxide; use as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis, such as psoriasis, arthritis, hemangioma, angiofibroma, eye diseases, cirrhosis of the liver |
| 12/02/2008 | US7459465 Isoquinoline compound and pharmaceutical use thereof |
| 12/02/2008 | US7459464 Triple monoamine reuptake inhibitors for the treatment of chronic pain |
| 12/02/2008 | US7459462 Water soluble groups on ring A; antitumor antibiotics; 1-Desoxy-5-C-[(8R)-4',9,9'-trihydroxy-6'-methoxy-1,1',3',5',8'-pentaoxo-1,1',2,3',5',6,7,8'-octahydrospiro[cyclopenta[g]isoquinoline-8,2'-cyclopenta[b]-naphthalene]-3-yl]pentitol; topoisomerase inhibitors; cyclodextrin inclusions; stereoisomers |
| 12/02/2008 | US7459459 8-(3-pentylamino)-2-methyl-3-(2-methyl-4-methoxyphenyl)-6,7-dihydro-5H-cyclopenta[d]pyrazolo[1,5-a]pyrimidine; corticotropin releasing factor receptor antagonist; antidepressant, anxiolytic agent; eating disorder, peptic ulcer, irritable bowl syndrome, Alzheimer's disease, drug addiction or alcoholism |
| 12/02/2008 | US7459458 Polymorph of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto |
| 12/02/2008 | US7459449 Olanzapine malonate, olanzapine glycolate, and olanzapine benzoate; antipsychotic agents; water soluble; can form tablets by direct compression; may be mixed with dibasic calcium phosphate and/or hydroxypropyl cellulose |
| 12/02/2008 | US7459442 Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
| 12/02/2008 | US7459427 Reducing glucagon production by administering a corticotrophin releasing factor receptor 2 antagonist, especially a Urocortin III analog; treating high body temperature, appetite dysfunction, congestive heart failure, vascular disease, stress and anxiety. |
| 12/02/2008 | US7459424 Peptide inhibitors of protein kinase C γ for pain management |
| 12/02/2008 | US7459171 Controlling flux of penetrants across adaptable, semipermeable porous barrier by enlarging applied dose per area of penetrants; drug delivery |
| 12/02/2008 | CA2516108C Polymorphs of donepezil hydrochloride and process for production |
| 12/02/2008 | CA2469315C Pharmaceutical nanoparticulate composition of a tachykinin receptor antagonist |
| 12/02/2008 | CA2460005C Enhancement of learning and memory and treatment of amnesia with the use of fused pyrazoles |
| 12/02/2008 | CA2372040C Imidazodiazepine derivative |
| 12/02/2008 | CA2361841C Mevinolin derivatives |
| 12/02/2008 | CA2333038C Sleep-inducing preparation |
| 12/02/2008 | CA2313878C Composition for suppressing behavior problems of pets |
| 12/02/2008 | CA2284170C Identification of agents for use in the treatment of alzheimer's disease |
| 12/02/2008 | CA2265672C Pyrazinones and triazinones and their derivatives thereof |
| 12/02/2008 | CA2215397C Inhibition of tau-tau-association |
| 12/02/2008 | CA2205085C An in vitro system for determining formation of a.beta. amyloid |
| 11/28/2008 | CA2590605A1 Improvement of mood, memory and cognitive function with pyridoxal 5'-phosphate |
| 11/28/2008 | CA2590603A1 Treatment of tardive dyskinesia with pyridoxal 5'-phosphate |
| 11/27/2008 | WO2008144665A1 Use of pimavanserin in the treatment of parkinson and symptoms thereof |
| 11/27/2008 | WO2008144473A2 Chimeric pufa polyketide synthase systems and uses thereof |
| 11/27/2008 | WO2008144394A2 Fused-ring heterocycle opioids |
| 11/27/2008 | WO2008144305A1 Diaryl-substituted tetrahydroisoquinolines as histamine h3 receptor and serotonin transporter modulators |
| 11/27/2008 | WO2008144299A1 5- (aminoazacyclyl) -3-sulfonyl-lh- indazoles as 5-hydroxytryptamine- 6 ligands for the treatment of cns disorders |
| 11/27/2008 | WO2008144065A1 Ophthalmic formulations of amyloid- contrast agents and methods of use thereof |
| 11/27/2008 | WO2008144061A2 Novel combinations comprising a phosphodiesterase-5 inhibitor and their use |
| 11/27/2008 | WO2008143875A1 Targeted delivery of glycine receptors to excitable cells |
| 11/27/2008 | WO2008143705A2 Methods and compositions for rapid inactivation of proteins |
| 11/27/2008 | WO2008143553A1 Medicinal agent for treating patients suffering from diseases caused by the monoaminooxidase excessive activity and a method for treating patients suffering from diseases caused by the monoaminooxidase excessive activity |